In the tumor-draining lymph nodes, mice treated with CpG-conjugated EVs also showed a higher CD8/Treg ratio and an increased number of CD69+ CD8+ T cells and memory-phenotype CD8+ T cells, in comparison with mice treated with EV alone or the mixture of EV and CpG (Fig. S17a–e). This evidence concerns the gene CD69 and neoplasm.